Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2007
10/09/2007US7279164 Chimeric proteins that induce effects directed against viruses
10/09/2007US7279163 Water-in-oil emulsion vaccines
10/09/2007US7279162 Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
10/09/2007US7279161 Treating patients afflicted with hemophilia A by administering an antibody that binds factor IX/factor IXa and increases the procoagulant activity of FIXa
10/09/2007US7279160 Combinations of DR5 antibodies and other therapeutic agents
10/09/2007US7279158 Methods for the treatment of inflammatory joint disease
10/09/2007US7279157 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
10/09/2007US7279149 Amino acid composition with increased blood brain barrier permeability
10/09/2007CA2455012C Enteral compositions for the prevention and/or treatment of sepsis
10/09/2007CA2312296C Pasteurella multocida toxoid vaccines
10/09/2007CA2272881C Assay method for peptide specific t-cells
10/09/2007CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use
10/09/2007CA2156416C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
10/04/2007WO2007112410A2 Tolerizing agents
10/04/2007WO2007112364A1 Methods for treating kidney disorders
10/04/2007WO2007112316A2 Mycobacterial immunotherapy for cancer treatment
10/04/2007WO2007112193A2 Camptothecin-binding moiety conjugates
10/04/2007WO2007112079A2 Multivalent immunogen
10/04/2007WO2007112047A2 Formulations containing immunotoxins targeted to the mesothelin tumor cell antigen
10/04/2007WO2007111964A2 Hepatitis c virus neutralizing antibodies
10/04/2007WO2007111940A2 Regimens for immunisation with meningococcal conjugates
10/04/2007WO2007111931A2 Compositions and methods relating to modulation of immune system components
10/04/2007WO2007111626A2 Arginase ii: a target for the prevention and treatment of atherosclerosis
10/04/2007WO2007111500A1 Immunization with transgenic mushrooms
10/04/2007WO2007111421A1 A method for treating tumor using irradiated tumor cell expressing human hepatitis b surface antigen and a pharmaceutical composition comprising the tumor cell
10/04/2007WO2007111326A1 Whole cell vaccine suffering from no toxicity return even in prolonged storage and use thereof
10/04/2007WO2007110776A1 Storage of influenza vaccines without refrigeration
10/04/2007WO2007110700A2 Chlamydial antigens
10/04/2007WO2007110678A2 Neutralizing antibodies and methods of use thereof
10/04/2007WO2007110632A1 Bacterial vaccine
10/04/2007WO2007110631A1 Binding member for gm-csf receptor
10/04/2007WO2007110602A1 Immunogenic compositions
10/04/2007WO2007110462A1 Tuberculosis vaccine
10/04/2007WO2007110409A1 Compositions comprising a recombinant adenovirus and an adjuvant
10/04/2007WO2007110339A1 Anti-igf-1r human monoclonal antibody formulation
10/04/2007WO2007110219A1 Medical delivery device for therapeutic proteins based on single domain antibodies
10/04/2007WO2007109825A1 Method for treating stage iv melanoma
10/04/2007WO2007109823A2 Peptide library
10/04/2007WO2007094754A3 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
10/04/2007WO2007094003A3 Viral display vehicles for treating multiple sclerosis
10/04/2007WO2007082734A3 Influenza vaccine
10/04/2007WO2007073567A3 Compositions and methods of modulating the immune response
10/04/2007WO2007071422A3 Pharmaceutical antibody compositions with resistance to soluble cea
10/04/2007WO2007068485A3 Biological materials and uses thereof
10/04/2007WO2007064742B1 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
10/04/2007WO2007048086A3 Canine influenza virus and related compositions and methods of use
10/04/2007WO2007047829A3 Novel heterodimeric proteins and uses thereof
10/04/2007WO2007047573A3 Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods
10/04/2007WO2007045389A3 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma
10/04/2007WO2007042289A3 Nanobodies™ and polypeptides against egfr and igf-ir
10/04/2007WO2007041219A3 Compositions and methods for il13 biomarkers
10/04/2007WO2007038637A3 Human monoclonal antibodies to cd70
10/04/2007WO2007026249A3 Multiple vaccination including serogroup c meningococcus
10/04/2007WO2007014003A3 Systems and methods for delivery of a therapeutic agent
10/04/2007WO2007007352B1 A vaccine for staphylococcal infections
10/04/2007WO2007002131A3 Galk1s as modifiers of the pten/akt pathway and methods of use
10/04/2007WO2006063800A8 Cloning of honey bee allergen
10/04/2007WO2005016239A3 Molecules enhancing dermal delivery of influenza vaccines
10/04/2007WO2004097000A3 Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions
10/04/2007WO2004071457A3 Improved heat shock protein-based vaccines and immunotherapies
10/04/2007US20070232556 Methods and compositions for the treatment of neurological diseases and disorders
10/04/2007US20070232535 GFRalpha3 and its uses
10/04/2007US20070231876 Purification Process for Bacterial Cytolysin
10/04/2007US20070231842 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis
10/04/2007US20070231839 N-(3-oxododecanoyl)-L-homoserine lactone, binding to carrier; used as vaccine or to raise and subsequently isolate antibodies or binding portions thereof which are capable of recognizing and binding to the autoinducer; carrier molecule comprises a lysine-containing protein, such as bovine serum albumin
10/04/2007US20070231408 Colloidal metal compositions and methods
10/04/2007US20070231378 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
10/04/2007US20070231351 isolating dendritic cells from a blood, bone marrow of a patient suffering from cancer or from an unrelated donor, culturing the dendritic cells under conditions and pulsing the dendritic cells with tumour cell lysate or an antigen released by the type of tumour cell and a tocotrienol
10/04/2007US20070231350 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine
10/04/2007US20070231349 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine
10/04/2007US20070231348 High titer recombinant influenza viruses for vaccines
10/04/2007US20070231347 Immunization Regimen with E4-Deleted Adenovirus Prime and E1-Deleted Adenovirus Boost
10/04/2007US20070231346 Apparatus and methods for vaccine development using ultrasound technology
10/04/2007US20070231344 Conjugate vaccines for non-proteinaceous antigens
10/04/2007US20070231343 Use of streptococcus suis 38 kDa polypeptide as an immunogen
10/04/2007US20070231342 immunogenic compositions comprising combinations of biological molecules from Neisseria bacteria, particularly N. meningitidis and N. gonorrhoeae
10/04/2007US20070231341 Cat dander allergen treatments
10/04/2007US20070231339 Fungal immunostimulatory compositions
10/04/2007US20070231337 heat shock proteins (Hsp70); metastatic neoplastic diseases, sarcomas, and carcinomas; humanizing, chimeric; monoclonal antibodies, hybridomas; inhibits natural killer cells
10/04/2007US20070231336 Immunization Against Clostridium Difficile Disease
10/04/2007US20070231335 Compositions and methods for treating Gram positive bacterial infection in a mammalian subject
10/04/2007US20070231334 Combination therapy for anthrax using antibiotics and protease inhibitors
10/04/2007US20070231333 Anti-5t4 antibodies and uses thereof
10/04/2007US20070231332 Inhibition of Cancer Metastasis
10/04/2007US20070231331 presenilin/G-protein/c-src binding polypeptides ; modulate the physiologic interactions of polypeptides required for the production of beta -amyloid (A beta ); drug screening
10/04/2007US20070231330 Method for the improvement of neuronal regeneration
10/04/2007US20070231329 Fc Variants Having Increased Affinity for FcyRIIb
10/04/2007US20070231328 Method of Treatment Using Humanized Anti-CD11a Antibodies
10/04/2007US20070231327 Anti-CCR5 antibodies
10/04/2007US20070231326 Immunological Methods of Treating Cancer
10/04/2007US20070231325 Prospective identification and characterization of breast cancer stem cells
10/04/2007US20070231324 Methods of using death receptor ligands and CD20 antibodies
10/04/2007US20070231323 Compositions and methods for the diagnosis and treatment of tumors of glial origin
10/04/2007US20070231322 Compositions and Methods for Treating Proliferative Disorders Such as Nk-Type Ldgl
10/04/2007US20070231321 Heavy and light chain variable domains; fv fragments; vectors, host cells; for oral diseases such as periodontitis and dental caries prevented effectively by passive immunization
10/04/2007US20070231320 Eggs having increased antibody titer and methods for making same
10/04/2007US20070231319 Methods of treating inflammatory and autoimmune diseases with natalizumab
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007US20070231317 S100 Protein Inhibitors for Treating Leukemia
10/04/2007US20070231316 Treatment of Cognitive Dysfunction in Lupus
1 ... 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 ... 1823